Literature DB >> 21799021

The non-canonical protein binding site at the monomer-monomer interface of yeast proliferating cell nuclear antigen (PCNA) regulates the Rev1-PCNA interaction and Polζ/Rev1-dependent translesion DNA synthesis.

Neeru M Sharma1, Olga V Kochenova, Polina V Shcherbakova.   

Abstract

Rev1 and DNA polymerase ζ (Polζ) are involved in the tolerance of DNA damage by translesion synthesis (TLS). The proliferating cell nuclear antigen (PCNA), the auxiliary factor of nuclear DNA polymerases, plays an important role in regulating the access of TLS polymerases to the primer terminus. Both Rev1 and Polζ lack the conserved hydrophobic motif that is used by many proteins for the interaction with PCNA at its interdomain connector loop. We have previously reported that the interaction of yeast Polζ with PCNA occurs at an unusual site near the monomer-monomer interface of the trimeric PCNA. Using GST pull-down assays, PCNA-coupled affinity beads pull-down and gel filtration chromatography, we show that the same region is required for the physical interaction of PCNA with the polymerase-associated domain (PAD) of Rev1. The interaction is disrupted by the pol30-113 mutation that results in a double amino acid substitution at the monomer-monomer interface of PCNA. Genetic analysis of the epistatic relationship of the pol30-113 mutation with an array of DNA repair and damage tolerance mutations indicated that PCNA-113 is specifically defective in the Rev1/Polζ-dependent TLS pathway. Taken together, the data suggest that Polζ and Rev1 are unique among PCNA-interacting proteins in using the novel binding site near the intermolecular interface of PCNA. The new mode of Rev1-PCNA binding described here suggests a mechanism by which Rev1 adopts a catalytically inactive configuration at the replication fork.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21799021      PMCID: PMC3190872          DOI: 10.1074/jbc.M110.206680

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases.

Authors:  Scott D McCulloch; Thomas A Kunkel
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

2.  A charged residue at the subunit interface of PCNA promotes trimer formation by destabilizing alternate subunit interactions.

Authors:  Bret D Freudenthal; Lokesh Gakhar; S Ramaswamy; M Todd Washington
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-05-15

3.  Yeast Rev1 protein promotes complex formation of DNA polymerase zeta with Pol32 subunit of DNA polymerase delta.

Authors:  Narottam Acharya; Robert E Johnson; Vincent Pagès; Louise Prakash; Satya Prakash
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

4.  Structure of a mutant form of proliferating cell nuclear antigen that blocks translesion DNA synthesis.

Authors:  Bret D Freudenthal; S Ramaswamy; Manju M Hingorani; M Todd Washington
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

Review 5.  Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance.

Authors:  Lauren S Waters; Brenda K Minesinger; Mary Ellen Wiltrout; Sanjay D'Souza; Rachel V Woodruff; Graham C Walker
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

6.  Complex formation of yeast Rev1 with DNA polymerase eta.

Authors:  Narottam Acharya; Lajos Haracska; Satya Prakash; Louise Prakash
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

7.  Translesional DNA synthesis through a C8-guanyl adduct of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Vitro: REV1 inserts dC opposite the lesion, and DNA polymerase kappa potentially catalyzes extension reaction from the 3'-dC terminus.

Authors:  Hirokazu Fukuda; Takeji Takamura-Enya; Yuji Masuda; Takehiko Nohmi; Chiho Seki; Kenji Kamiya; Takashi Sugimura; Chikahide Masutani; Fumio Hanaoka; Hitoshi Nakagama
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

8.  Participation of DNA polymerase zeta in replication of undamaged DNA in Saccharomyces cerevisiae.

Authors:  Matthew R Northam; Heather A Robinson; Olga V Kochenova; Polina V Shcherbakova
Journal:  Genetics       Date:  2009-10-19       Impact factor: 4.562

9.  Novel conserved motifs in Rev1 C-terminus are required for mutagenic DNA damage tolerance.

Authors:  Sanjay D'Souza; Lauren S Waters; Graham C Walker
Journal:  DNA Repair (Amst)       Date:  2008-07-07

10.  Identification of a novel, widespread, and functionally important PCNA-binding motif.

Authors:  Karin M Gilljam; Emadoldin Feyzi; Per A Aas; Mirta M L Sousa; Rebekka Müller; Cathrine B Vågbø; Tara C Catterall; Nina B Liabakk; Geir Slupphaug; Finn Drabløs; Hans E Krokan; Marit Otterlei
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

View more
  25 in total

1.  The vital role of polymerase ζ and REV1 in mutagenic, but not correct, DNA synthesis across benzo[a]pyrene-dG and recruitment of polymerase ζ by REV1 to replication-stalled site.

Authors:  Keiji Hashimoto; Youngjin Cho; In-Young Yang; Jun-ichi Akagi; Eiji Ohashi; Satoshi Tateishi; Niels de Wind; Fumio Hanaoka; Haruo Ohmori; Masaaki Moriya
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

2.  Avoidance of APOBEC3B-induced mutation by error-free lesion bypass.

Authors:  James I Hoopes; Amber L Hughes; Lauren A Hobson; Luis M Cortez; Alexander J Brown; Steven A Roberts
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

Review 3.  Modulation of mutagenesis in eukaryotes by DNA replication fork dynamics and quality of nucleotide pools.

Authors:  Irina S-R Waisertreiger; Victoria G Liston; Miriam R Menezes; Hyun-Min Kim; Kirill S Lobachev; Elena I Stepchenkova; Tahir H Tahirov; Igor B Rogozin; Youri I Pavlov
Journal:  Environ Mol Mutagen       Date:  2012-10-10       Impact factor: 3.216

4.  Small-molecules that bind to the ubiquitin-binding motif of REV1 inhibit REV1 interaction with K164-monoubiquitinated PCNA and suppress DNA damage tolerance.

Authors:  Murugendra Vanarotti; Benjamin J Evison; Marcelo L Actis; Akira Inoue; Ezelle T McDonald; Youming Shao; Richard J Heath; Naoaki Fujii
Journal:  Bioorg Med Chem       Date:  2018-03-19       Impact factor: 3.641

5.  Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polζ Suggests a Mechanism of Polymerase Exchange upon Rev1/Polζ-Dependent Translesion Synthesis.

Authors:  Yulia Pustovalova; Mariana T Q Magalhães; Sanjay D'Souza; Alessandro A Rizzo; George Korza; Graham C Walker; Dmitry M Korzhnev
Journal:  Biochemistry       Date:  2016-03-24       Impact factor: 3.162

6.  Rev1 recruits ung to switch regions and enhances du glycosylation for immunoglobulin class switch DNA recombination.

Authors:  Hong Zan; Clayton A White; Lisa M Thomas; Thach Mai; Guideng Li; Zhenming Xu; Jinsong Zhang; Paolo Casali
Journal:  Cell Rep       Date:  2012-11-08       Impact factor: 9.423

Review 7.  Eukaryotic DNA polymerase ζ.

Authors:  Alena V Makarova; Peter M Burgers
Journal:  DNA Repair (Amst)       Date:  2015-02-19

8.  PCNA trimer instability inhibits translesion synthesis by DNA polymerase η and by DNA polymerase δ.

Authors:  Lynne M Dieckman; M Todd Washington
Journal:  DNA Repair (Amst)       Date:  2013-03-15

9.  A small molecule inhibitor of monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin.

Authors:  Akira Inoue; Sotaro Kikuchi; Asami Hishiki; Youming Shao; Richard Heath; Benjamin J Evison; Marcelo Actis; Christine E Canman; Hiroshi Hashimoto; Naoaki Fujii
Journal:  J Biol Chem       Date:  2014-01-28       Impact factor: 5.157

10.  Structural Basis for the Interaction of Mutasome Assembly Factor REV1 with Ubiquitin.

Authors:  Gaofeng Cui; Maria Victoria Botuyan; Georges Mer
Journal:  J Mol Biol       Date:  2018-05-18       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.